Eli Lilly taps veteran Lucas Montarce as new CFO

jetcityimage/iStock Editorial via Getty Images Eli Lilly and Company ( NYSE: LLY ) on Monday announced the appointment of Lucas Montarce as executive vice president and chief financial officer and member of the company's Executive Committee, effective immediately. Montarce has been with Lilly since 2001, holding various finance leadership roles, including: Group Vice President, Corporate Controller, and CFO of Lilly Research Laboratories Vice President, Finance, and CFO of Lilly International Vice President, Finance, and Global CFO of Elanco Health Most recently, Montarce served as President and General Manager for the Spain, Portugal, and Greece hub. David A.

Ricks, chair and CEO commented, "Developing leadership talent has always been a strength for Lilly, and Lucas has thrived in a wide variety of roles of increasing scope and impact. Having worked directly with Lucas for more than a decade, I am highly confident he has the drive, curiosity, and integrity to excel as our next CFO." More on Eli Lilly Eli Lilly and Company (LLY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript) Eli Lilly: Zepbound Price Cuts Have Multiple Positives, Limited Downside Eli Lilly: Tirzepatide's Winning Streak Continues Eli Lilly bets $409M for AI-focused drug discovery Eli Lilly marks late-stage trial win for once weekly insulin.